Please wait while the transcript is being prepared...
0:00
Good morning.
My name is Dr.
Oyindamola Ogunlaja.
I'm a clinical
assistant professor
in the Department of Neurology
at Stanford University.
The title of this talk is
the Epidemiology and Global
Burden of Headache Disorders,
with a particular
emphasis on migraine.
0:20
Primary headache disorders,
in particular migraine,
are a common cause of
disability worldwide.
They're associated with higher
rates of mental health disorders,
such as anxiety and depression,
and reduced economic
productivity,
which negatively impacts the gross
domestic product on a national scale.
In 2016, almost 3
billion people worldwide
were estimated to have migraine
or tension-type headache,
1.89 billion with
tension-type headache
and 1.04 billion with migraine.
0:53
Through the Global
Burden of Disease study,
we have a better understanding
of the scale and impact
of headache disorders worldwide.
The Global Burden
of Disease study,
which I'll refer to
as GBD from now on,
is a worldwide collaboration
currently led by
the Institute for Health
Metrics and Evaluation,
which is part of the
University of Seattle.
It aims to quantify health loss due
to different diseases and injuries
across places and over time.
It's been performed
periodically since 1990,
with the latest
iteration being in 2019.
In this presentation,
we'll talk about the gross worldwide
statistics of headache disorders
and then break down into
region-by-region analyses
of the prevalence of
headache disorders
and the burden
attributable to them.
